Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza
- 1 February 2003
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 22 (2) , 164-177
- https://doi.org/10.1097/01.inf.0000050458.35010.b6
Abstract
Prompt testing for influenza can help guide clinical management of patients with suspected influenza. Three antiviral medications, amantadine, oseltamivir and zanamivir, are approved for treatment of influenza in children. Rimantadine and ribavirin have also been used. To review the published evidence on clinically useful diagnostic tests and antiviral treatment for influenza virus infections in children. Studies published from 1966 through September 2002 were reviewed on clinical diagnosis, immunofluorescence and rapid influenza tests and on antiviral treatment of influenza virus infections among pediatric populations. No studies assessed the accuracy of clinical diagnosis of influenza in children compared with viral culture. Compared with viral culture, direct immunofluorescence antibody and indirect immunofluorescence antibody tests for influenza had fair to moderate median sensitivities and high median specificities, whereas rapid influenza diagnostic tests had moderate median sensitivities and moderately high median specificities. No randomized, placebo-controlled studies were found of amantadine or rimantadine for treatment of influenza A. In a few separate controlled studies, oseltamivir, zanamivir and ribavirin each reduced symptom duration of influenza compared with placebo. Additional data are needed about the accuracy of clinical diagnosis of influenza in children. Although direct immunofluorescence antibody staining, indirect immunofluorescence antibody staining and rapid tests are moderately to reasonably accurate in detecting influenza virus infections in children, physicians should use clinical judgment and local surveillance data about circulating influenza viruses when interpreting test results. Further controlled studies of the efficacy, adverse effects and emergence of antiviral resistance during treatment of influenza are needed for all of the antiviral drugs.Keywords
This publication has 72 references indexed in Scilit:
- Evaluation of a New Dot Blot Enzyme Immunoassay (Directigen Flu A+B) for Simultaneous and Differential Detection of Influenza A and B Virus Antigens from Respiratory SamplesJournal of Clinical Microbiology, 2002
- Predicting Influenza Infections during Epidemics with Use of a Clinical Case DefinitionClinical Infectious Diseases, 2000
- Evaluation of a direct immunofluorescence assay, dot-blot enzyme immunoassay, and shell vial culture in the diagnosis of lower respiratory tract infections caused by influenza a virusDiagnostic Microbiology and Infectious Disease, 1996
- Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: A double-blind, multicenter, placebo-controlled trialThe Journal of Pediatrics, 1994
- Rapid detection of influenza-B virus in respiratory secretions by immunofluorescence during an epidemicDiagnostic Microbiology and Infectious Disease, 1992
- Influenza A virus infection imitating bacterial sepsis in early infancyThe Pediatric Infectious Disease Journal, 1984
- VIRAL INFECTIONS OF THE RESPIRATORY TRACT IN HOSPITALIZED CHILDREN A Study from Oslo during a 90 Months’PeriodActa Paediatrica, 1983
- Interpandemic Influenza in the Houston Area, 1974–76New England Journal of Medicine, 1978
- CLINICAL EVALUATION OF 1‐β‐D‐RIBOFURANOSYL‐1,2,4‐TRIAZOLE‐3‐CARBOXAMIDE (RIBAVIRIN) IN A DOUBLE‐BLIND STUDY DURING AN OUTBREAK OF INFLUENZAAnnals of the New York Academy of Sciences, 1977
- Influenzavirus A2 Infections Presenting with Febrile Convulsions and Gastrointestinal Symptoms in Young ChildrenClinical Pediatrics, 1976